U.S. Markets open in 25 hrs, 19 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 4.30 09:32 AM EST | |
|---|---|---|
| Day High | 4.65 10:21 AM EST |
|
| Range | 0.35 |
| Volume | 35,848 | |
|---|---|---|
| 30-Day Avg Vol | 45,000 |
|
| Difference | -20.34% |
| Market Cap | 113.08 M | |
|---|---|---|
| Mkt Cap Chg | -5.55 M |
| Shares Out | 25.24 M | |
|---|---|---|
| % Shrs Traded | 0.14% | |
| 1yr EPS Est | -2.413 |
| 52-Wk Low | 1.15 | |
|---|---|---|
| 52-Wk High | 7.90 |
|
| Range | 6.75 |
| Prev Close | 4.70 11/5/09 | |
|---|---|---|
| Today's Open | 4.55 | |
| Change | -3.19% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 1.01 M |
| Revenue (LFY) | 474,559 | |
|---|---|---|
| Earnings (LFY) | -81.25 M | |
| Earnings (MRQ) | -16.62 M | |
| Next Earn Est | -0.679 | |
| Next Earnings | 11/09/2009 |
|
| EPS (TTM) | -2.89 | |
| 1yr EPS Growth | 16.51% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -1.00 | |
| PEG Ratio | — | |
| Return on Equity | — | |
| Beta | — |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Broken hearts are hard to mend, but Molecular Insight Pharmaceuticals (MIP) is working to change that. The development-stage company is focused on making molecular imaging and radiotherapeutic products ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.679 11/9/09 | — — |
—
—
|
| Last Quarter | -0.593 6/30/09 | -0.66 6/30/09 |
-0.067
Missed
|
| 2 Quarters Ago | -0.62 3/31/09 | -0.61 3/31/09 |
0.01
Beat
|
| Quarterly - 06/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 137,274.00 | 474,559.00 |
| Gross Profit | -111,541.00 | -428,034.00 |
| Operating Income | -11.62 M | -61.92 M |
| Net Income | -16.62 M | -81.25 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts